Conservative surgery for T2 > 3 cm, T3 N0 N1 M0 breast cancer after induction chemotherapy;La chirurgie conservatrice des cancers du sein T2 > 3 cm, T3 N0 N1 M0 après chimiothérapie d'induction

Bulletin du Cancer

Volumn 88, Issue 2, 2001, Pages 175-180

  Bobin, J Y ^a   Zinzindohoue, C ^a   Faure Virelizier, C ^a   Joulai, A ^a   Khaled, M ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Breast cancer; Chemotherapy induction; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER SIZE; CANCER STAGING; CANCER SURGERY; HUMAN; LYMPH NODE BIOPSY; PLASTIC SURGERY; REVIEW; SENTINEL LYMPH NODE; TUMOR VOLUME;

BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY, SEGMENTAL; NEOPLASM STAGING; REMISSION INDUCTION;

EID: 0035075546     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Traitement médical d'induction et cancer du sein
2. Scientific basis for adjuvant and primary (neoadjuvant) chemotherapy
3. Effect of surgical removal on the growth and kinetics of residual tumor
4. Effect of preoperative chemotherapy on locoregional in women with operable breast cancer: Findings from national surgical adjuvant breast and bowel project B 18
5. Effect of preoperative therapy for primary breast cancer (BC) on local regional disease, disease free survival (DFS) and survival (S): Results from NSABP B18
6. Randomized trial of chemo-endocrine therapy started before or after surgery for treatment of primary breast cancer
7. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicenter randomized trial with a 124 months median follow up
8. Chimiothérapie première dans les cancers du sein opérables supérieurs à 3 cm: Résultats de trois protocoles
9. Sequential assessment of multidrug resistance phenotype and mesurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy
10. High dose multimodality therapy with autologues stem-cell support for stade III B breast carcinoma
11. The management of ductal and lobular breast cancer
12. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumors considered too large for breast conserving surgery: Preliminary results of a randomized trial S6
13. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin based neoadjuvant chemotherapy
14. Conservation surgery after primary chemotherapy in large carcinoma of the breast
15. La chimiothérapie néo-adjuvante dans le cancer du sein: Rôle de la chirurgie en cas de réponse clinique complète
16. Management of locally advanced carcinoma of the breast non inflammatory
17. Primary chemotherapy with primary radiotherapy: A possibility to preserve the breast in large tumor
18. A reduction in the requirement for mastectomy in randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer
19. The feasability of minimal invasive surgery for stade II A, II B and III A breast carcinoma patients after tumor down staging with induction chemotherapy
20. Advanced primary breast cancer: Assessment of mammography of response to induction chemotherapy
21. Utility of magnetic resonance magnetic imaging in the management of breast cancer: Evidence for improved preoperative staging
22. The role of primary chemotherapy in early breast cancer
23. Evaluation of neoadjuvant chemotherapy responde of locally advanced breast cancer by magnetic resonance
24. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant chemotherapy
25. Locally advanced breast cancer: Contrast enhanced substraction MR imaging of response to preoperative chemotherapy
26. Reduction in angiogenesis after neoadjuvant chemo-endocrine therapy in patients with operable breast cancer
27. Neoadjuvant chemotherapy in young breast cancer patients: Correlation between responde and relapse?
28. Résultats à 10 ans d'un essai randomisé de chimiothérapie néoadjuvante dans le cancer du sein de plus de 3 cm
29. Le traitement conservateur après radiothérapie dans le cancer du sein
30. Conservative treatment feasability with induction chemotherapy, surgery and radiotherapy for patients with breast carcinoma larger than 3 cm
31. Results of a conservatrice treatment combining induction (neoadjuvant) and consolidation chemotherapy hormonotherapy and external and interstitial irradiation in 98 patients with locally advanced breast cancer (III A, III B)
32. Régression tumorale comme facteur pronostique dans le cancer du sein
33. Selection of local therapy after neoadjuvant chemotherapy in patients with stage III A, B
34. Mastectomy following preoperative chemotherapy
35. Extending the indications for breast conserving treatment to patients with locally advanced breast cancer
36. Neoadjuvant chemotherapy locally advanced breast cancer, and quality of life
37. Role of axillary lymph node dissection after down staging with induction chemotherapy for locally advanced breast cancer
38. Tagging sentinel lymph nodes: A study of 100 patients with breast cancer
39. Sentinel lymphadenectomy in breast cancer
40. Sentinel lymph node biopsy to avoid axillary dissection in breast cancer with clinical negative lymph nodes
41. Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors
42. Primary axillary radiotherapy as axillary treatment in breast conserving therapy for patients with breast carcinoma and clinically negative lymph nodes